Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Assure Holdings Corp IONM

Assure Holdings Corp. is a provider of outsourced intraoperative neurophysiological monitoring (IONM) and remote neurology services. The Company delivers a suite of clinical and operational services to support surgeons and medical facilities during invasive procedures. Its IONM tool is used for various surgical verticals, such as neurosurgery, spine, ear, nose, and throat, and other surgical... see more

NDAQ:IONM - Post Discussion

Assure Holdings Corp > Excellent news
View:
Post by synectix on Jul 06, 2021 9:31am

Excellent news

Assure Sets Monthly Record for Cash Collection and Procedures in June 2021

GlobeNewswire - 1 hour ago

Assure Holdings Corp. (the "Company" or "Assure") (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services ("IONM"), announced a monthly record for cash collection and number of procedures during June 2021.

John A. Farlinger, executive chairman and CEO said, "Assure has invested heavily in revenue cycle management, including the recent hiring of a chief information officer who will help accelerate our digital transformation and analytical capabilities, the staffing of a 28-person internal billing and collections team and migrating to a platform that has an automated and integrated process, transitioning from what had historically been an entirely manual system."

Results and expectations relating to billing and collections include:

-- The Company collected a monthly record $2.7 million in June 2021. This includes collection of $1.6 million for IONM revenue that it retains 100%.

-- Assure has collected more than $0.8 million of pre-acquisition accounts receivable owed to Sentry Neuromonitoring, LLC, a Texas-based IONM service provider the Company acquired on April 30, 2021.

-- Based upon recent discussions with various insurance providers, Assure expects to continue the strong trend of collections in 2021.

Farlinger continued, "Assure is continuing to partner with insurance companies via in-network agreements helping the Company deliver better and more predictable results with less volatility. Looking into the second half of 2021, we do not anticipate significant volatility with respect to our revenue accrual per procedure given that both our existing in-network contracts and those we are currently negotiating, are comparable to our current accrual rates. This will continue to be a focus for Assure as we attempt to migrate more revenue into agreements with insurance companies."

Company Reports Record Number of Procedures

Farlinger concluded, "The Company reported more than 1,600 cases in June 2021, our highest number of monthly procedures ever. We are continuing to show particular strength in Texas and are benefitting from the Company's professional neurology services for IONM launched earlier this year, which is boosting our total number of cases performed. Assure continues to expect our case volume to grow by at least 70% in 2021."

Assure Continues to Ramp-Up Telehealth Professional Neurology Services

Assure onboarded its second remote supervising professional supporting the Company's telehealth professional neurology services in June 2021. Dr. Diego Tovar is a board-certified neurologist and epileptologist specializing in the comprehensive care of patients with epilepsy, the interpretation of all electroencephalogram ("EEG") modalities including prolonged video EEG, quantitative EEG, and intracranial EEG, planning of epilepsy surgery with implantation of intracranial electrodes, stereo EEG and use of neuro-modulation treatments.

Before joining Assure, Dr. Tovar served as a neurologist and epileptologist in the St. David's Healthcare System and an assistant clinical professor at the University of Texas Medical Branch at Galveston. Dr. Tovar was also an epilepsy and clinical neurophysiology fellow at the Mayo Clinic. Prior to that he was a resident neurologist at Mount Sinai Beth Israel and an internal medicine resident at Montefiore Medical Center.

The Company expects to gradually ramp-up staffing for its telehealth professional neurology services function over the course of 2021 and beyond.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities